Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing
Cancer Letters · 2023-11 · 577 · 216425
DOI: 10.1016/j.canlet.2023.216425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2023-11. Verfasst von Yan Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, University of Macau, Taipa, Macau. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lactate Dehydrogenase 5, Lung Neoplasms, Pyruvate Dehydrogenase Acetyl-Transferring Kinase. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Universidade de Macau, Fundo para o Desenvolvimento das Ciências e da Tecnologia.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) is one of the most prevalent and aggressive types of lung cancer. Metabolic reprogramming plays a critical role in the development and progression of LUAD. Pyruvate dehydrogenase kinase 1 (PDK1) and lactate dehydrogenase A (LDHA) are two key enzymes involved in glucose metabolism, whilst their aberrant expressions are often associated with tumorigenesis. Herein, we investigated the anticancer effects of combined inhibition of PDK1 and LDHA in LUAD in vitro and in vivo and its underlying mechanisms of action. The combination of a PDK1 inhibitor, 64, and a LDHA inhibitor, NHI-Glc-2, led to a synergistic growth inhibition in 3 different LUAD cell lines and more than additively suppressed tumor growth in the LUAD xenograft H1975 model. This combination also inhibited cellular migration and colony formation, while it induced a metabolic shift from glycolysis to oxidative phosphorylation (OXPHOS) resulting in mitochondrial depolarization and apoptosis in LUAD cells. These effects were related to modulation of multiple cell signaling pathways, including AMPK, RAS/ERK, and AKT/mTOR. Our findings demonstrate that simultaneous inhibition of multiple glycolytic enzymes (PDK1 and LDHA) is a promising novel therapeutic approach for LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Sciences, University of Macau, Taipa, Macau.
- Dipartimento di Farmacia, Università di Pisa, 56126, Pisa, Italy.
- Department of Medical Oncology, Amsterdam University Medical Centers, Location VUmc, Cancer Center Amsterdam, 1081, HV Amsterdam, the Netherlands; Fondazione Pisana per La Scienza, Pisa, Italy.
- Department of Biochemistry, Medical University of Gdansk, 80-210, Gdańsk, Poland; Department of Medical Oncology, Amsterdam University Medical Centers, Location VUmc, Cancer Center Amsterdam, 1081, HV Amsterdam, the Net…
- Faculty of Health Sciences, University of Macau, Taipa, Macau. Electronic address: kintam@um.edu.mo.
Förderung
- Universidade de Macau
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
Zitieren
APA
Zhou, Y., Guo, Y., Ran, M., Shan, W., Granchi, C., Giovannetti, E., Minutolo, F., Peters, G. J., & Tam, K. Y. (2023). Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing. Cancer Letters, 577, 216425. https://doi.org/10.1016/j.canlet.2023.216425
Vancouver
Zhou Y, Guo Y, Ran M, Shan W, Granchi C, Giovannetti E, et al. Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing. Cancer Letters. 2023;577:216425. doi:10.1016/j.canlet.2023.216425
BibTeX
@article{Zhou2023,
author = {Zhou, Yan and Guo, Yizhen and Ran, Maoxin and Shan, Wenying and Granchi, Carlotta and Giovannetti, Elisa and Minutolo, Filippo and Peters, Godefridus J and Tam, Kin Yip},
title = {Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing},
journal = {Cancer Letters},
year = {2023},
volume = {577},
pages = {216425},
doi = {10.1016/j.canlet.2023.216425}
}
EUVIMED